Effi Capital Nadlan Ltd (TLV:EFCP)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,739.00
-115.00 (-6.20%)
At close: Aug 5, 2025, 5:14 PM IDT
bluebird bio Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 460.36 | 444.95 | 410.51 | 638.39 | 206.4 | 58.74 | |
Revenue Growth (YoY) | 21.37% | 8.39% | -35.70% | 209.30% | 251.38% | - |
Cost of Revenue | 385.05 | 367.74 | 307.55 | 508.49 | 165.93 | 36.84 |
Gross Profit | 75.31 | 77.21 | 102.96 | 129.9 | 40.47 | 21.9 |
Selling, General & Admin | 40.24 | 40.47 | 29.21 | 22.99 | 15.3 | 10.69 |
Other Operating Expenses | 0.57 | - | 0.14 | - | 0.41 | - |
Operating Expenses | 40.8 | 40.47 | 29.35 | 22.99 | 15.71 | 10.69 |
Operating Income | 34.51 | 36.73 | 73.62 | 106.91 | 24.76 | 11.21 |
Interest Expense | -40 | -37.05 | -22.84 | -9.43 | -13.89 | -7.61 |
Interest & Investment Income | 28.82 | 29.27 | 32.12 | 8.63 | 1.8 | 3.05 |
Earnings From Equity Investments | 5.9 | 11.47 | 20.99 | 72.87 | 46.88 | 31.67 |
Currency Exchange Gain (Loss) | -0.3 | -0.3 | - | - | - | - |
EBT Excluding Unusual Items | 28.93 | 40.12 | 103.89 | 178.98 | 59.55 | 38.33 |
Gain (Loss) on Sale of Investments | -3.45 | -3.45 | 2.76 | -4.18 | -1.08 | - |
Gain (Loss) on Sale of Assets | 0.56 | 0.56 | 1.98 | - | 0.11 | - |
Asset Writedown | - | - | 0.15 | -4.65 | - | - |
Other Unusual Items | - | - | 3.24 | - | - | - |
Pretax Income | 26.05 | 37.23 | 112.02 | 170.16 | 58.57 | 38.33 |
Income Tax Expense | 3.89 | 5.73 | 22.78 | 22.91 | 2.9 | 1.51 |
Earnings From Continuing Operations | 22.15 | 31.5 | 89.24 | 147.25 | 55.67 | 36.82 |
Earnings From Discontinued Operations | - | - | -0.2 | 1.88 | -1.34 | -5.25 |
Net Income | 22.15 | 31.5 | 89.04 | 149.12 | 54.33 | 31.57 |
Net Income to Common | 22.15 | 31.5 | 89.04 | 149.12 | 54.33 | 31.57 |
Net Income Growth | -71.61% | -64.62% | -40.29% | 174.46% | 72.13% | - |
Shares Outstanding (Basic) | 46 | 45 | 37 | 37 | 37 | - |
Shares Outstanding (Diluted) | 46 | 45 | 37 | 37 | 37 | - |
Shares Change (YoY) | 22.36% | 22.11% | - | - | - | - |
EPS (Basic) | 0.48 | 0.70 | 2.42 | 4.06 | 1.48 | - |
EPS (Diluted) | 0.48 | 0.70 | 2.42 | 4.06 | 1.48 | - |
EPS Growth | -76.95% | -71.11% | -40.29% | 174.46% | - | - |
Free Cash Flow | -338.54 | -183.4 | -301.76 | 35.71 | -21.14 | 46.92 |
Free Cash Flow Per Share | -7.31 | -4.09 | -8.21 | 0.97 | -0.57 | - |
Dividend Per Share | 0.110 | 0.110 | 0.330 | 0.330 | - | - |
Dividend Growth | -66.67% | -66.67% | - | - | - | - |
Gross Margin | 16.36% | 17.35% | 25.08% | 20.35% | 19.61% | 37.28% |
Operating Margin | 7.50% | 8.26% | 17.93% | 16.75% | 11.99% | 19.08% |
Profit Margin | 4.81% | 7.08% | 21.69% | 23.36% | 26.32% | 53.74% |
Free Cash Flow Margin | -73.54% | -41.22% | -73.51% | 5.59% | -10.24% | 79.87% |
EBITDA | 41.64 | 42.64 | 76.61 | 108.94 | 26.47 | 12.47 |
EBITDA Margin | 9.04% | 9.58% | 18.66% | 17.06% | 12.82% | 21.24% |
D&A For EBITDA | 7.13 | 5.91 | 3 | 2.03 | 1.71 | 1.27 |
EBIT | 34.51 | 36.73 | 73.62 | 106.91 | 24.76 | 11.21 |
EBIT Margin | 7.50% | 8.26% | 17.93% | 16.75% | 11.99% | 19.08% |
Effective Tax Rate | 14.95% | 15.39% | 20.34% | 13.46% | 4.95% | 3.94% |
Revenue as Reported | 460.36 | 444.95 | 410.51 | 638.39 | 206.4 | 58.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.